Klotho Neurosciences, Inc.
KLTO
$1.54
$0.042.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.59M | 1.85M | 2.87M | 395.60K | 672.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.59M | 1.85M | 2.87M | 395.60K | 672.00K |
| Operating Income | -1.59M | -1.85M | -2.87M | -395.60K | -672.00K |
| Income Before Tax | -2.23M | -2.07M | -2.96M | -451.60K | -672.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.23M | -2.07M | -2.96M | -451.60K | -672.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.23M | -2.07M | -2.96M | -451.60K | -672.00K |
| EBIT | -1.59M | -1.85M | -2.87M | -395.60K | -672.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.08 | -0.08 | -0.18 | -0.03 | -0.04 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.11 | -0.02 | -0.03 |
| EPS Diluted | -0.08 | -0.08 | -0.18 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.11 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 27.52M | 27.22M | 16.69M | 15.68M | 15.13M |
| Average Diluted Shares Outstanding | 27.52M | 27.22M | 16.69M | 15.68M | 15.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |